Xenon Pharmaceuticals Inc. (XENE) stock: key figures, P/E, revenue and dividend
Health Care · ISIN US98420N1054
Xenon Pharmaceuticals Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 7.50 m USD |
| Operating income | -373.07 m USD |
| EBIT | -371.72 m USD |
| Net income | -345.91 m USD |
| Diluted EPS – continuing operations | -4.36 USD |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders. Its product candidates include Azetukalner, a novel, potent Kv7 potassium channel opener which is in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. In addition, the company's Phase 1 Single Ascending Dose/Multiple Ascending Dose products include XEN1701 targeting the sodium channel and XEN1120 targeting the Kv7 potassium channel for the treatment of pain. The company has a license and collaboration agreement with Neurocrine Biosciences, Inc. for the development of NBI-921355, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
More stocks
- Sacyr SA (SCYR.MC)
- Kinik Co (1560.TW)
- Trina Solar Co Ltd (688599.SS)
- Pacific Securities Co Ltd (601099.SS)
- Vidrala SA (VID.MC)
- Dormakaba Holding AG (DOKA.SW)
- Life360, Inc. (LIF)
- COLUMBIA SPORTSWEAR CO (COLM)
- Caihong Display Devices Co Ltd (600707.SS)
- APPIAN CORP (APPN)
- Andon Health Co Ltd (002432.SZ)
- Structure Therapeutics Inc. (GPCR)
Not investment advice. All data without warranty, price as of 02.11.2026. Details in the risk notice.